Articles

Articles 30 registres trobats  anterior11 - 20següent  anar al registre: La cerca s'ha fet en 0.00 segons. 
11.
10 p, 450.6 KB Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries / Fonseca, Francina 1972- (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Lenahan, William (Rocky Mountain Poison and Drug Safety (Estats Units d'Amèrica)) ; Dart, Richard C. (Rocky Mountain Poison and Drug Safety (Estats Units d'Amèrica)) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Dargan, Paul I. (King's College London) ; Wood, David M. (King's College London) ; Guareschi, Marilena (Association for the Application of Neuroscientific Knowledge to Social Aims (Itàlia)) ; Maremmani, Icro (University of Pisa) ; Auriacombe, Marc (Centre Hospitalier Universitaire (França)) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Scherbaum, Norbert (University Hospital Essen (Alemanya)) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Background: Non-medical use (NMU) of prescription GABA analogs (pregabalin and gabapentin) has been reported especially in opiate dependent persons. However, by now the prevalence of NMU of gabapentinoids in the general population has not been sufficiently evaluated. [...]
2021 - 10.3389/fpsyt.2021.676224
Frontiers in psychiatry, Vol. 12 (april 2021)  
12.
17 p, 415.5 KB Drug Interactions With New Synthetic Opioids / Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fonseca, Francina 1972- (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Farré, Adriana (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Fentanyl, fentanyl analogs, and other new synthetic opioids (NSO) have burst onto the illegal drug market as new psychoactive substances (NPS). They are often sold as heroin to unsuspecting users and produce euphoria through their agonist action on μ- opioid receptors. [...]
2018 - 10.3389/fphar.2018.01145
Frontiers in Pharmacology, Vol. 9 (october 2018)  
13.
10 p, 487.7 KB Acute Pharmacological Effects of 2C-B in Humans : An Observational Study / Papaseit, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez-Mañá, Clara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Ventura, Mireia (Energy Control, Associació Benestar i Desenvolupament) ; Pujadas, Mitona (Institut Hospital del Mar d'Investigacions Mèdiques) ; De La Torre, Rafael (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; González, Débora (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia
2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT), 5-hydroxytryptamine-2B (5-HT), and 5-hydroxytryptamine-2C (5-HT) receptor partial agonist used recreationally as a new psychoactive substance. [...]
2018 - 10.3389/fphar.2018.00206
Frontiers in Pharmacology, Vol. 9 (march 2018)  
14.
14 p, 1.4 MB The Tryptophan System in Cocaine-Induced Depression / Fonseca, Francina 1972- (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Mestre-Pintó, Joan-Ignasi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Gomez-Gomez, A (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martinez-Sanvisens, Diana (Hospital del Mar (Barcelona, Catalunya)) ; Rodríguez-Minguela, Rocío (Institut Hospital del Mar d'Investigacions Mèdiques) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Langohr, Klaus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Valverde, Olga (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pozo, Óscar J. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. [...]
2020 - 10.3390/jcm9124103
Journal of clinical medicine, Vol. 9 (december 2020)  
15.
9 p, 1.2 MB Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis / Pérez-Acevedo, Ana Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Busardo, Francesco Paolo (Università Politecnica delle Marche, Italy) ; Pacifici, Roberta (Istituto Superiore di Sanità, Rome, Italy) ; Mannocchi, Giulio (University of Camerino, Italy) ; Gottardi, Massimo (Comedical srl, Trento, Italy) ; Poyatos, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Martin, Soraya (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Di Trana, Annagiulia (Università Politecnica delle Marche, Ancona, Italy) ; Pichini, Simona (Istituto Superiore di Sanità, Rome, Italy) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
The use of cannabis flowering tops with standardized amounts of active phytocannabinoids was recently authorized in several countries to treat several painful pathological conditions. The acute pharmacological effects and disposition of Δ-9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors and THC metabolites after oil and decoction administration have been already described. [...]
2020 - 10.3390/ph13120459
Pharmaceuticals, Vol. 13 (december 2020)  
16.
14 p, 1.3 MB Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS / La Maida, Nunzia (University "Politecnica delle Marche" of Ancona) ; Pellegrini, Manuela (National Centre on Addiction and Doping, Rome) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Poyatos, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ventura, Mireia (Energy Control, Associació Benestar i Desenvolupament) ; Galindo, Liliana (Energy Control, Associació Benestar i Desenvolupament) ; Busardo, Francesco Paolo (University "Politecnica delle Marche" of Ancona) ; Pichini, Simona (National Centre on Addiction and Doping, Rome) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Marchei, Emilia (National Centre on Addiction and Doping, Istituto Superiore di Sanità, V.Le Regina Elena 299, 00161 Rome, Italy; (S.P.); (E.M.))
The consumption of synthetic cannabinoids (SCs) has significantly increased in the last decade and the analysis of SCs and their metabolites in human specimens is gaining interest in clinical and forensic toxicology. [...]
2020 - 10.3390/ijms21249414
International journal of molecular sciences, Vol. 21 (december 2020)  
17.
9 p, 1.1 MB UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers / Pellegrini, Manuela (National Centre on Addiction and Doping, Rome) ; Marchei, Emilia (National Centre on Addiction and Doping, Rome) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Zaami, Simona (Università Roma La Sapienza)
Background and Objectives : The use of synthetic cannabinoids has increased around the world. As a result, the implementation of accurate analysis in human biological matrices is relevant and fundamental. [...]
2020 - 10.3390/medicina56080408
Medicina, Vol. 56 (august 2020)  
18.
14 p, 991.2 KB Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users / Maida, Nunzia La (Università Politecnica delle Marche (Ancona, Itàlia). Department of Excellence of Biomedical Science and Public Health) ; Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Martínez, Lucia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez-Mañá, Clara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Poyatos, Lourdes (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pellegrini, Manuela (Istituto Superiore di Sanità (Roma, Itàlia). National Centre on Addiction and Doping) ; Pichini, Simona (Istituto Superiore di Sanità (Roma, Itàlia). National Centre on Addiction and Doping) ; Pacifici, Roberta (Istituto Superiore di Sanità (Roma, Itàlia). National Centre on Addiction and Doping) ; Ventura, Mireia (Associació Benestar i Desenvolupament (Barcelona)) ; Galindo, Liliana (Associació Benestar i Desenvolupament (Barcelona)) ; Busardo, Francesco Paolo (Università Politecnica delle Marche (Ancona, Itàlia). Department of Excellence of Biomedical Science and Public Health) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
UR-144 is a synthetic cannabinoid found in herbal incenses for recreational use as a substitute of cannabis. It is a cannabinoid receptor agonist with effects on the central nervous system similar to those of THC. [...]
2021 - 10.3390/biology10040257
Biology, Vol. 10 Núm. 4 (march 2021)  
19.
9 p, 999.0 KB Long-Term Outcomes of Patients With Cocaine Use Disorder : A 18-years Addiction Cohort Study / Sanvisens, Arantza (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernandez-Rubio, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Zuluaga Cruz, Andrea Paola (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fuster, Daniel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Papaseit, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Galan, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Muga, Roberto (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Objective: Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i. [...]
2021 - 10.3389/fphar.2021.625610
Frontiers in Pharmacology, Vol. 12 (february 2021)  
20.
13 p, 1013.2 KB Acute Pharmacological Effects of Oral and Intranasal Mephedrone : an observational study in humans / Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Olesti, Eulàlia (Universitat Pompeu Fabra) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Fonseca, Francina 1972- (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Grifell, Marc (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Ventura, Mireia (Associació Benestar i Desenvolupament) ; De La Torre, Rafael (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Mephedrone (4-methylmethcathinone) is a synthetic cathinone with psychostimulant properties which remains one of the most popular new psychoactive substances (NPS). It is frequently used orally and/or intranasally. [...]
2021 - 10.3390/ph14020100
Pharmaceuticals, Vol. 14 Núm. 2 (2021) , p. 100  

Articles : 30 registres trobats   anterior11 - 20següent  anar al registre:
Vegeu també: autors amb noms similars
1 Papaseit, E.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.